Arcus Biosciences develops late-stage immunotherapies, with Domvanalimab and Casdatifan leading the way. See why I rate RCUS ...

Gilead’s twice-yearly injection for HIV prevention cut infections by 96% in a late-stage trial, the company said Thursday, ...

Urban Outfitters Inc. URBN is currently trading at a notably low price-to-earnings (P/E) multiple, which is below the Zacks Retail-Apparel and Shoes industry and broader Retail-Wholesale averages.

Over the past three decades, rates of colon cancer among young people have been steadily rising even as diagnoses among older ...

Analysts have recently evaluated Rhythm Pharmaceuticals and provided 12-month price targets. The average target is $59.5, ...

(OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced the first patient enrolled in a Phase I dose ...

Tolerability issues for CT-388 and CT-996 may impact Roche Holdings AG, but strong pipeline prospects remain. Discover why ...

After the war ended in 1945, Hibray flew over Hiroshima to view the devastation and into Osaka, where he purchased an Arisaka ...

Through three games in the 2024 NFL season, it appears the Chicago Bears are getting their bearings on who should be getting ...

Alzheimers and Dementia Society Chairperson, Jeanette Ochello, has thanked everyone who took part in the weekend's Memory ...

Aspirin is a popular drug with people of all ages — but one heart surgeon says not everybody should be popping the pain reliever. Dr. Jeremy London took to TikTok to share his expert intel on who ...

New management simulation game TCG Card Shop Simulator is exploding on Steam, as it hits 'overwhelmingly positive' after just ...